Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.04 EUR | +0.89% | +2.51% | +18.69% |
Apr. 29 | Colgate-Palmolive's Strong Q1 Results Support Outperformance, Morgan Stanley Says | MT |
Apr. 29 | Stifel Nicolaus Adjusts Colgate-Palmolive Price Target to $95 From $94, Maintains Buy Rating | MT |
Sales 2024 * | 20.18B 18.85B | Sales 2025 * | 21.01B 19.63B | Capitalization | 74.24B 69.34B |
---|---|---|---|---|---|
Net income 2024 * | 2.87B 2.68B | Net income 2025 * | 3.11B 2.91B | EV / Sales 2024 * | 4.04 x |
Net Debt 2024 * | 7.31B 6.83B | Net Debt 2025 * | 7B 6.54B | EV / Sales 2025 * | 3.87 x |
P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
23.7
x | Employees | 34,000 |
Yield 2024 * |
2.23% | Yield 2025 * |
2.33% | Free-Float | 56% |
Latest transcript on Colgate-Palmolive Company
1 day | +0.89% | ||
1 week | +2.51% | ||
Current month | +1.78% | ||
1 month | +1.78% | ||
3 months | +10.01% | ||
6 months | +22.27% | ||
Current year | +18.69% |
Managers | Title | Age | Since |
---|---|---|---|
Noel Wallace
CEO | Chief Executive Officer | 59 | 86-12-31 |
Stanley Sutula
DFI | Director of Finance/CFO | 58 | 20-11-08 |
Stephan Habif
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Harris
BRD | Director/Board Member | 67 | 16-03-13 |
John Bilbrey
BRD | Director/Board Member | 68 | 15-03-10 |
John Cahill
BRD | Director/Board Member | 66 | 05-10-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 85.04 | +0.89% | 18 |
24-04-26 | 84.29 | +1.14% | 310 |
24-04-25 | 83.34 | +0.56% | 7 |
24-04-24 | 82.88 | -0.28% | 100 |
24-04-23 | 83.11 | +0.18% | 131 |
Delayed Quote Deutsche Boerse AG, April 29, 2024 at 07:13 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.32% | 381B | |
+8.03% | 129B | |
-16.39% | 62.59B | |
+0.37% | 52.86B | |
-11.47% | 36.11B | |
+2.76% | 33.57B | |
+9.68% | 17.29B | |
+7.68% | 14.75B | |
-9.06% | 10.82B |
- Stock Market
- Equities
- CL Stock
- CPA Stock